These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8835755)

  • 1. Leukoencephalitis after recombinant hepatitis B vaccine.
    Manna R; De Santis A; Oliviero A; Carnevale A; Caputo S; Pahor M; Laudisio A; Gasbarrini G
    J Hepatol; 1996 Jun; 24(6):764-5. PubMed ID: 8835755
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome after recombinant hepatitis B vaccine.
    Macário F; Freitas L; Correia J; Campos M; Marques A
    Clin Nephrol; 1995 May; 43(5):349. PubMed ID: 7634556
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6/11/16/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines.
    Wheeler CM; Bautista OM; Tomassini JE; Nelson M; Sattler CA; Barr E;
    Vaccine; 2008 Jan; 26(5):686-96. PubMed ID: 18164106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute myelitis after immunization against hepatitis B with recombinant vaccine].
    Senejoux A; Roulot D; Belin C; Tsakiris L; Rautureau J; Coste T
    Gastroenterol Clin Biol; 1996; 20(4):401-2. PubMed ID: 8758508
    [No Abstract]   [Full Text] [Related]  

  • 5. Guillain-Barré syndrome following hepatitis B vaccination.
    Khamaisi M; Shoenfeld Y; Orbach H
    Clin Exp Rheumatol; 2004; 22(6):767-70. PubMed ID: 15638054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major adverse reactions to yeast-derived hepatitis B vaccines--a review.
    Grotto I; Mandel Y; Ephros M; Ashkenazi I; Shemer J
    Vaccine; 1998 Feb; 16(4):329-34. PubMed ID: 9607051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Causative immunopathologic mechanisms in pediatric urticaria following primary injection with anti-hepatitis B vaccine].
    Barbaud A; Reichert-Pénétrat S; Béné MC; Kolopp-Sarda MN; Faure G; Kohler C; Schmutz JL
    Ann Dermatol Venereol; 2000; 127(6-7):662-3. PubMed ID: 11041825
    [No Abstract]   [Full Text] [Related]  

  • 8. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient.
    Konstantinou D; Paschalis C; Maraziotis T; Dimopoulos P; Bassaris H; Skoutelis A
    Clin Infect Dis; 2001 Nov; 33(10):1772-3. PubMed ID: 11595974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombocytopenic purpura after recombinant hepatitis B vaccine.
    Poullin P; Gabriel B
    Lancet; 1994 Nov; 344(8932):1293. PubMed ID: 7967998
    [No Abstract]   [Full Text] [Related]  

  • 10. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure.
    Watkins SL; Alexander SR; Brewer ED; Hesley TM; West DJ; Chan IS; Mendelman P; Bailey SM; Burns JL; Hogg RJ;
    Am J Kidney Dis; 2002 Aug; 40(2):365-72. PubMed ID: 12148110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability of a recombinant DNA hepatitis B vaccine--results of post-marketing surveillance.
    Singh S; Sharma DR
    J Commun Dis; 1999 Mar; 31(1):53-5. PubMed ID: 10810588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of immunogenicity and safety of Engerix B and Twinrix vaccine].
    Gałaj A; Grześk G; Borys D; Durmowicz A; Grześk E; Szadujkis-Szadurski L
    Wiad Lek; 2004; 57(5-6):217-20. PubMed ID: 15518064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis.
    Fabrizi F; Di Filippo S; Marcelli D; Guarnori I; Raffaele L; Crepaldi M; Erba G; Locatelli F
    Nephron; 1996; 72(4):536-43. PubMed ID: 8730417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prophylactic hepatitis B vaccine with a novel adjuvant system.
    Thoelen S; De Clercq N; Tornieporth N
    Vaccine; 2001 Mar; 19(17-19):2400-3. PubMed ID: 11257368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy, safety and immunogenicity of Hepavax-Gene and Engerix-B, recombinant hepatitis B vaccines, in infants born to HBsAg and HBeAg positive mothers in Vietnam: an assessment at 2 years.
    Hieu NT; Kim KH; Janowicz Z; Timmermans I
    Vaccine; 2002 Mar; 20(13-14):1803-8. PubMed ID: 11906768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic anemia and thrombocytopenic purpura after the administration of the recombinant hepatitis B vaccine].
    Llimiñana C; Soler JA; Melo M; Roig I
    Med Clin (Barc); 1999 Jun; 113(1):39. PubMed ID: 10422080
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe acute hepatitis B infection after vaccination.
    Ballinger AB; Clark ML
    Lancet; 1994 Nov; 344(8932):1292. PubMed ID: 7734013
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual loss and eosinophilia after recombinant hepatitis B vaccine.
    Brézin A; Lautier-Frau M; Hamedani M; Rogeaux O; Hoang PL
    Lancet; 1993 Aug; 342(8870):563-4. PubMed ID: 8102709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.